Scotia Capital Inc. Has $14.11 Million Stock Position in CME Group Inc. (NASDAQ:CME)

Key Points

• Scotia Capital Inc. increased its holdings in CME Group by 3.3% during the first quarter, bringing its total stake to $14.11 million with 53,177 shares owned.
• CME Group reported $2.96 earnings per share for its latest quarter, exceeding expectations and marking a 10.4% year-over-year revenue growth.
• The company declared a quarterly dividend of $1.25 per share, resulting in an annualized dividend of $5.00 with a yield of 1.8%.

Scotia Capital Inc. raised its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 3.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 53,177 shares of the financial services provider's stock after acquiring an additional 1,695 shares during the quarter. Scotia Capital Inc.'s holdings in CME Group were worth $14,107,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Cheviot Value Management LLC acquired a new position in CME Group in the 1st quarter valued at approximately $79,000. Bank of Nova Scotia Trust Co. increased its position in CME Group by 4.9% in the 1st quarter. Bank of Nova Scotia Trust Co. now owns 25,820 shares of the financial services provider's stock valued at $6,850,000 after acquiring an additional 1,201 shares during the period. J. Safra Sarasin Holding AG increased its position in CME Group by 8.9% in the 1st quarter. J. Safra Sarasin Holding AG now owns 490,770 shares of the financial services provider's stock valued at $130,196,000 after acquiring an additional 40,012 shares during the period. Bank of Nova Scotia increased its position in shares of CME Group by 6.4% during the first quarter. Bank of Nova Scotia now owns 290,079 shares of the financial services provider's stock worth $76,954,000 after buying an additional 17,568 shares during the period. Finally, OVERSEA CHINESE BANKING Corp Ltd acquired a new stake in shares of CME Group during the first quarter worth $718,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Up 0.9%

Shares of NASDAQ CME opened at $280.76 on Monday. The firm has a market cap of $101.18 billion, a PE ratio of 27.18, a P/E/G ratio of 4.99 and a beta of 0.44. CME Group Inc. has a 12-month low of $196.62 and a 12-month high of $290.79. The company's fifty day simple moving average is $276.07 and its 200 day simple moving average is $264.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the firm earned $2.56 earnings per share. CME Group's revenue was up 10.4% on a year-over-year basis. As a group, sell-side analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio (DPR) is 48.40%.

Insider Transactions at CME Group

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the firm's stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $272.56, for a total value of $817,680.00. Following the transaction, the director directly owned 5,400 shares of the company's stock, valued at approximately $1,471,824. This trade represents a 35.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of the firm's stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $273.17, for a total transaction of $81,951.00. Following the completion of the transaction, the director directly owned 24,767 shares in the company, valued at $6,765,601.39. This trade represents a 1.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 5,750 shares of company stock valued at $1,576,294. Corporate insiders own 0.30% of the company's stock.

Analyst Ratings Changes

CME has been the subject of several recent analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. UBS Group reiterated a "neutral" rating and set a $305.00 price objective on shares of CME Group in a research report on Thursday, July 24th. Oppenheimer increased their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. Keefe, Bruyette & Woods increased their price objective on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research report on Thursday, April 24th. Finally, Erste Group Bank cut shares of CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the company. According to MarketBeat, CME Group has a consensus rating of "Hold" and an average target price of $261.93.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.